IANNONE, LUIGI FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 349
EU - Europa 160
AS - Asia 22
SA - Sud America 6
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 539
Nazione #
US - Stati Uniti d'America 347
IT - Italia 86
SE - Svezia 26
DE - Germania 8
FI - Finlandia 7
GB - Regno Unito 7
MT - Malta 7
CO - Colombia 4
ES - Italia 4
IN - India 4
IR - Iran 4
NL - Olanda 4
TR - Turchia 4
UA - Ucraina 3
CA - Canada 2
LT - Lituania 2
MN - Mongolia 2
OM - Oman 2
RO - Romania 2
TH - Thailandia 2
BR - Brasile 1
CH - Svizzera 1
CL - Cile 1
CN - Cina 1
EG - Egitto 1
EU - Europa 1
FR - Francia 1
HR - Croazia 1
JP - Giappone 1
RU - Federazione Russa 1
SG - Singapore 1
TW - Taiwan 1
Totale 539
Città #
Chandler 115
Catanzaro 21
Princeton 16
Lawrence 15
Ashburn 14
Wilmington 9
Los Angeles 8
Des Moines 7
Helsinki 7
Chicago 6
Casalnuovo di Napoli 5
London 4
Rome 4
Induno Olona 3
Malatya 3
Montegiordano 3
Redwood City 3
Zejtun 3
Benevento 2
Bogotá 2
Bollebygd 2
Castelliri 2
Catania 2
Cernusco sul Naviglio 2
Esslingen am Neckar 2
Faenza 2
Louisville 2
Melita 2
Muscat 2
Nakhon Sawan 2
New York 2
Ottawa 2
Philadelphia 2
Phoenix 2
Pune 2
Redmond 2
Taurianova 2
Vigo 2
Vilnius 2
West Jordan 2
Amsterdam 1
Belpasso 1
Boardman 1
Boston 1
Cairo 1
Cittanova 1
Constanța 1
Crawfordsville 1
Falls Church 1
Florence 1
Frankfurt am Main 1
Geislingen an der Steige 1
Istanbul 1
Kastav 1
La Canada Flintridge 1
Madrid 1
Meggen 1
Messina 1
Mumbai 1
Nagold 1
Nanjing 1
Naples 1
Nijmegen 1
Novokuznetsk 1
Pacoima 1
Pamplona 1
Queens 1
Sharif 1
Singapore 1
Slough 1
Taipei 1
Taormina 1
Tehran 1
Timisoara 1
Tokyo 1
Ulan Bator 1
Totale 326
Nome #
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 84
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 56
Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug–Drug Interactions and Tolerability 37
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study 34
Management of status epilepticus in patients with liver or kidney disease: a narrative review 34
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP) 33
Assessing knowledge and attitudes toward epilepsy among schoolteachers and students: Implications for inclusion and safety in the educational system 29
Microbiota-gut brain axis involvement in neuropsychiatric disorders 28
Renal denervation for resistant hypertension 27
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 27
Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice 25
Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox–Gastaut Syndrome 24
Status epilepticus in pregnancy: a literature review and a protocol proposal 23
The microbiota-gut-brain axis and epilepsy from a multidisciplinary perspective: Clinical evidence and technological solutions for improvement of in vitro preclinical models 23
Ixekizumab May Improve Renal Function in Psoriasis 21
Safety profile of biologics used in rheumatology: An italian prospective pharmacovigilance study 19
Appropriate use of generic and branded antiseizure medications in epilepsy: Updated recommendations from the Italian League Against Epilepsy (LICE) 16
The CHRONOS Real-World: Evidence of Biologic Treatments in Psoriatic Arthritis in Italy: A Post Hoc Gender Analysis. 15
null 7
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 2
Totale 564
Categoria #
all - tutte 4.471
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.471


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 0 11 1 0 1 2 4 3
2020/202174 0 0 0 0 13 17 20 4 11 3 6 0
2021/202280 0 0 1 26 4 5 0 12 6 5 15 6
2022/2023299 31 45 4 31 29 30 5 21 57 20 25 1
2023/202489 11 11 15 4 12 12 5 10 3 6 0 0
Totale 564